HAVN Life Sciences Inc.
CSE: HAVN, 5NP.F
Company Overview
Havn Life Sciences is a biotechnology company on a mission to unlock human potential using evidence-informed research. The company is focused on standardized, quality-controlled extraction of psychoactive compounds from plants and fungi, and the development of natural health care products from non-regulated compounds.
Financial Highlights
$586,976
Revenue (ttm)
$89,693
Gross Profit (ttm)
-$3.11
Diluted EPS (ttm)
Management Team
Mr. Tim Moore
Interim CFO, CEO & Chairman
Ms. Jenna Pozar
Chief Operations Officer
Mr. Paul More
Controller
Key Highlights
Market Capitalization
$3,722,736
Shares Outstanding
66,771,000
Shares Short (% of Float)
()
Insider Ownership
5%